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Abstract
Mycobacterium avium subsp. hominissuis (Mah) represents a health concern for humans
and to a lesser extent for pigs, but its zoonotic potential remains elusive. Using multispacer
sequence typing (MST) we previously identified 49 different genotypes of Mah among Bel-
gian clinical and porcine isolates, with 5 MSTs shared by both hosts. Using experimental
intranasal infection of BALB/c mice, we compared the virulence and immunogenicity of por-
cine and clinical human isolates with shared genotype or with a genotype only found in
humans or pigs. Bacterial replication was monitored for 20 weeks in lungs, spleen and liver
and mycobacteria specific spleen cell IFN-γ, IL-10 and IL-17 production as well as serum
antibody responses were analyzed. Isolates varied in virulence, with human and porcine iso-
lates sharing MST22 genotype showing a thousand fold higher bacterial replication in lungs
and more dissemination to spleen and liver than the human and porcine MST91 isolates.
Virulent MST22 type was also associated with progressive suppression of IFN-γ and IL-17
responses, and increased IL-10 production. Whole genome sequencing of the two virulent
isolates with MST22 genotype and two avirulent isolates of genotype MST91 and compari-
son with two well-studied M. avium subsp. hominissuis reference strains i.e. Mah 104 and
Mah TH135, identified in the two MST22 isolates nine specific virulence factors of the mam-
malian cell entry family, that were identical with Mah 104 strain. Despite the obvious limita-
tions of the mouse model, a striking link of virulence and identity at the genome level of
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porcine and human isolates with the same multisequence type, for which no correlation of
place of residence (humans) or farm of origin (pigs) was observed, seems to point to the
existence in the environment of certain genotypes of Mah which may be more infectious
both for humans and pigs than other genotypes.
Introduction
Among non-tuberculous mycobacteria (NTM), bacteria of the Mycobacterium avium complex
(MAC) are the most frequently isolated from patients [1,2]. The M. avium species is divided
into four subspecies: M. avium subsp. avium (Maa), M. avium subsp. silvaticum (Mas), M.
avium subsp. paratuberculosis (Map) and M. avium subsp. hominissuis (Mah) [3,4]. Recently, a
phylogenetic study showed that Mah represents diverse groups of organisms from which two
distinct groups, Map and Maa/Mas, have evolved independently [5]. These four subspecies of
M. avium are genetically close but they differ widely in their host range and pathogenicity.
Indeed, Map is responsible for an intestinal illness in ruminants known as Johne’s disease [6]
and could be implicated in human Crohn’s disease [7]. Maa and Mas mainly infect birds caus-
ing a tuberculosis-like disease, whereas Mah is a frequent agent of human and pig mycobacter-
ioses [8–10]. As indicated by its name, M. avium subsp. hominissuis is the most frequently
recovered M. avium subspecies in swine, although Maa can also be found. Although both sub-
species can infect pigs, Agdestein et al. observed more extensive shedding of Mah than of Maa,
which might explain the higher incidence of infection caused by the former subspecies [9,11].
In humans, Mah is the causative pathogen of two main types of disease: disseminated dis-
ease in immunocompromised hosts, such as AIDS patients and pulmonary disease in individu-
als without systemic immunosuppression [12]. Moreover, an association between Mah and
human lymphadenitis has been described by Despierres et al. [13]. In a retrospective study of
67 MAC-infected patients diagnosed between July 1996 and March 2011, Mah was isolated
from 24 out of 25 lymphadenitis patients, who were significantly younger than 42 non-lymph-
adenitis patients. Also, cervical topography found in 76.5% of lymphadenitis patients was sig-
nificantly more frequent in non-immunocompromised patients (p = 0.04) [14]. In the French
study, multispacer sequence typing (MST) of Mah isolates revealed an enormous genetic vari-
ability with 15 genotypes in 29 non-lymphadenitis isolates (molecular diversity, 0.622) versus
11 genotypes in 24 lymphadenitis isolates (molecular diversity, 0.578) [13]. Using the same
multispacer sequence typing method as described by Despierres et al., we previously identified
49 different genotypes of Belgian Mah among pig isolates collected during 2012–2013 (11
MST types) and among clinical human isolates collected during 2011–2012 (43 MST types),
and we observed that only 5 of these MST genotypes were shared by both hosts [15]. MST12
and MST22 genotypes were frequently found both in human and in pigs, whereas MST15, the
second most frequently observed type in humans, was not detected in pigs. In the Despierres
et al. study, 12/67 clinical isolates were typed as MST13 whereas in our study only 2/92 clinical
isolates had that genotype [13]. In contrast, in France only 1/67 isolates had the MST22 geno-
type (isolated from a 40 years old male patient with pulmonary disease) whereas in our study
MST22 genotype was found in 5/92 clinical isolates (and in 7/54 porcine isolates). Finally,
MST12 genotype was not detected in the French study, whereas in Belgium this was really the
preponderant genotype (16/92 human and 28/54 porcine isolates). In order to determine the
evolution of M. avium infecting pigs over time, we recently performed a subspecies determina-
tion and genotyping on two older panels of porcine isolates (collected in 1967–1968 and 1992–
1996). Unlike the omnipresence of Mah reported among the 2012–2013 isolates, a significant
Virulence and genetic diversity of M. hominissuis
PLOS ONE | DOI:10.1371/journal.pone.0171895 February 9, 2017 2 / 19
Tuberculosis & Mycobacteria is partially supported
by the Belgian Ministry of Social Affairs through a
fund within the Health Insurance System. The
funders played no role in the study design, data
collection and analysis, decision to publish, or
preparation of the manuscript. Genoscreen
provided support in the form of salaries for author
OC, but did not have any additional role in the study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing interests: Ophe´lie Chapeira is
employed by Genoscreen. There are no patents,
products in development or marketed products to
declare. This does not alter our adherence to all the
PLOS ONE policies on sharing data and materials,
as detailed online in the guide for authors.
Abbreviations: CODA-CERVA, Centrum voor
Onderzoek in Diergeneeskunde en Agrochemie-
Onderzoek- Centre d’Etude et de Recherches
Ve´te´rinaires et Agrochimiques; CODA-PIB-WIV,
Centrum voor Onderzoek in Diergeneeskunde en
Agrochemie-Pasteur Instituut van Brussel-
Wetenschappelijk Instituut voor Volksgezondheid;
IFN-γ, interferon-gamma; IL, interleukin; IgG,
Immunoglobulin; MAC, Mycobacterium avium
complex; MST, multispacer sequence type; Mce,
mammalian cell entry; ni-NTA, nickel-
nitrilotriacetic acid; NO, nitric oxide; NTM, non
tuberculous mycobacteria; OADC, oleic acid-
albumin-dextrose-catalase; OPD, o-
phenylenediamine; PPD, purified protein derivative
(of tuberculin); CF-A, culture filtrate of M. avium;
PPE, proline-proline-glutamic acid; PE, proline-
glutamic acid; SR-21, Specific Region 21; WIV-ISP,
Wetenschappelijk Instituut voor Volksgezondheid-
Institut de Sante´ Publique.
presence of both Maa and Mah, was observed in these older panels. Multispacer sequence
types (MST) changed over time, although MST12 was already the predominant genotype in
the older Mah panels as well (Soetaert et al., submitted for publication).
As Mah represents an increasing public health concern given its pathogenicity for humans,
a detailed comparison of human clinical isolates and swine isolates could contribute to estab-
lish or exclude any epidemiological link between both hosts. Here we report on a comparison
of bacterial replication and immunogenicity of Mah isolates with defined MST type in an
experimental mouse model.
Since Mah has been recovered from the environment, more particularly in sawdust and
peat [16], an intranasal infection was used to mimic airway exposure. We have previously
shown that the BALB/c mouse strain shows the same susceptibility to M. avium subsp. paratu-
berculosis infection as the mutant C57BL/6 bg/bg mouse strain (considered to be the best mouse
model for Mycobacterium avium complex disease [17]) and can be used for assessing mycobac-
terial virulence by monitoring bacterial replication in spleen, lungs and liver, as well as for
immunogenicity studies [18].
BALB/c mice were infected by the intranasal route with four human and four porcine Mah
isolates, with a shared MST genotype or with an MST genotype only found in humans or pigs.
Bacterial replication was monitored for 20 weeks in lungs, spleen and liver and mycobacteria
specific spleen cell IFN-γ, IL-10 and IL-17 production as well as serum antibody responses
were analyzed.
For a porcine and human isolate with shared MST22 genotype and for a porcine and
human isolate with shared MST91 genotype, we previously described the full genome sequenc-
ing [19], and in this paper we compared these sequences to those of two well-studied M. avium
subsp. hominissuis reference strains i.e. Mah 104 [20] and Mah TH135 [21].
Materials and methods
Ethics statement
Clinical isolates of Mah were used with the approval of the ethical committee of Hoˆpital
Erasme (ULB) (reference P2014/028). The study protocol was approved by the Ethical Com-
mittee of the Centrum voor Onderzoek in Diergeneeskunde en Agrochemie-Pasteur Instituut
van Brussel-Wetenschappelijk Instituut voor Volksgezondheid regulations (CODA-PIB-WIV,
permit number: 060202–02, President Dr. Els Goossens).
Clinical and porcine isolates
Table 1 shows the list of the eight Mah isolates used in this study. The four clinical human
isolates of Mah were isolated from patients diagnosed by the Tuberculosis & Mycobacteria
National Reference Laboratory of the Scientific Institute of Public Health (WIV-ISP) in Bel-
gium in 2012 and the last trimester of 2011. Porcine Mah isolates were isolated from subman-
dibular lymph nodes with visible lesions (identified after veterinary inspection in 2012–2013
by the UREAR-ULg) by the Belgian veterinary centre CODA-CERVA. The different porcine
Mah isolates originated from different farms, and farm location had no relation with the
selected human isolates [15].
Mah identification and MST typing
M. avium species identification was realized as a routine activity of the reference laboratory, by
sequencing of the gene coding for the 16SrRNA, as previously described [22]. All the Mah iso-
lates were identified at the subspecies level by sequencing of the PCR-amplified rpoB gene and
Virulence and genetic diversity of M. hominissuis
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by IS1245/IS901 analysis. Genotyping of the Mah isolates was performed by Multispacer
Sequence Typing MST. The PCR amplification of the spacers MST2, MST4, MST15 and
MST16 was realized as described by Cayrou et al. [23]. Purification of the amplicons and
sequencing was realized as described above, with the same forward and reverse primers as
used for the different MST PCRs [23]. The MST type was determined by consultation of the
MST database of the “Universite´ de la Me´diterrane´e” accessible via the following link: http://
ifr48.timone.univ-mrs.fr/mst/mycobacterium_avium/
In total 49 different genotypes of Mah were identified among pigs (11 MST types among 54
isolates) and humans (43 MST types among 92 isolates), with only 5 MST types shared by both
hosts [15]. As we have previously indicated, no correlation was observed between MST type
and place of residence or the farm of origin for human and porcine isolates respectively [15].
Mah cultivation
The Mah isolates were grown in plastic Roux flasks in liquid Middlebrook 7H9 medium (BD,
Franklin Lakes, NJ, USA), containing 10% Oleic Acid-Albumin-Dextrose-Catalase, for 14 days
at 39˚C under static aerobic conditions in horizontal position to maximize oxygen supply. Bac-
teria were harvested by centrifugation, washed three times with PBS and then frozen at -80˚C
in Middlebrook 7H9 medium supplemented with 20% glycerol until use. After one freeze/
thaw cycle and 2 min sonication, stocks were enumerated by plating serial dilutions on Mid-
dlebrook 7H11 (BD, Franklin Lakes, NJ, USA) supplemented with 10% OADC. The list of the
eight Mah isolates used for infection is given in Table 1.
Whole genome sequencing
Whole genome sequencing was performed on the human and porcine MST22 isolates and on
the human and porcine MST91 isolates, with an ILLUMINA Miseq 2X150 bp and a quality
analysis was realized using FastQC v0.11.5. Total genome sequence length and number of pro-
tein coding sequences were previously reported and whole sequences have been deposited at
the European Nucleotide Archive [19]. For the sake of clarity, the 12_062, 12_067, LYM122
and LYM086 isolates have been renamed here as Hu22, Hu91, Po22 and Po91 respectively.
Mice
Female BALB/c mice aged 6–8 weeks were bred and kept (5 animals per standard cage) at the
WIV-ISP experimental animal facilities (Site Ukkel), complying with the Belgian legislation
Table 1. List of the porcine and human M. avium subsp. hominissuis isolates used in this study.
Human clinical Mah isolates
Isolate name MST code Ref. name in [19] Age Sex Symptoms
Hu12 12 12_009 Unknown Female Unknown
Hu15 15 12MY0204 4 years Female Lymphadenitis
Hu22 22 12_062 40 years Male HIV neg, disseminated
Hu91 91 12_067 40 years Male AIDS, disseminated
Porcine Mah isolates
Isolate name MST code Ref. name in [19] Symptoms
Po12 12 LYM108 Mandibular lymphadenitis
Po22 22 LYM122 Mandibular lymphadenitis
Po91 91 LYM86 Mandibular lymphadenitis
Po103 103 LYM119 Mandibular lymphadenitis
doi:10.1371/journal.pone.0171895.t001
Virulence and genetic diversity of M. hominissuis
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that transposes European Directive 2009/41/EC, repealing Directive 90/219/EC (EC, 2009). All
efforts were made to minimize animal suffering. Anaesthesia was performed using isoflurane.
Experimental infection
Mice were infected by the intranasal route with 107 CFU of Mah. Infection dose was verified
by plating serial dilutions on solid Middlebrook 7H11 agar supplemented with 10% OADC.
After blood sampling, animals (n = 5/group at each time point) were sacrificed by cervical dis-
location. Two infection runs were realized, one run with the eight isolates and mice sacrificed
at week 1, 5, 10 and 20 weeks post-infection and a second run with seven of the eight isolates
(Hu15 isolate missing), and with time-point measures at 5, 9 and 20 weeks post-infection.
Non-infected mice were used as negative control. Spleen, lungs and liver of individual animals
were removed aseptically. Bacteria were enumerated by plating serial threefold organ dilutions
in duplicate on solid Middlebrook 7H11 agar supplemented with 10% OADC. Petri dishes
were incubated for 14 days at 39˚C and number of colonies were counted visually.
Cytokine production
Spleens were collected at week 5 and week 20 post-infection and homogenized using a loosely
fitting Dounce homogenizer. Leucocytes (4 x 106 cells/mL as measured in a Coulter Counter)
were cultivated at 37˚C in a humidified CO2 incubator in round-bottom microwell plates in a
volume of 200 μL RPMI-1640 medium (Life Technologies, Carlsbad, CA, USA) supplemented
with 5 x 10−5 M 2-mercaptoethanol, 1% penicillin-streptomycin and 10% fetal calf serum
(FCS). Spleen cells of five mice per group were analysed individually. Cells were stimulated
with Culture Filtrate (CF) of Map [24] or with purified recombinant E. coli-expressed Map
proteins at a final concentration of 5 μg/mL [24,25]. Culture supernatants were harvested after
72h. Supernatants were stored frozen at -20˚C until analysis.
Cytokine ELISA
IFN-γ, IL-10 and IL-17A were quantified in 72h culture supernatants of spleen cell cultures
using a sandwich enzyme-linked immunosorbent assay (ELISA). IFN-γ was detected using
coating antibody R4-6A2 and biotinylated detection antibody XMG1.2 (BD Pharmingen,
Franklin Lakes, NJ, USA). Plates were revealed with O-phenylenediamine dihydrochloride
substrate (OPD; Sigma-Aldrich, St. Louis, MO, USA); the reaction was stopped with 1 M
H2SO4, and the optical density was read at 490 nm. IL-10 and IL-17A were detected with com-
mercial ELISA kits (eBioscience, San Diego, CA, USA).
Characteristics of 35 recombinant Map proteins
The list of 35 Map proteins is given in Table 2. Antigens 1–18 were previously identified by
proteomic and immunoproteomic analysis of standard Map biofilm culture filtrate of bacteria
grown as a surface pellicle on synthetic Sauton medium [26]. Antigens 19–24 were identified
using an in silico analysis of Map genome [27]. Finally, antigens 25–35 were identified by
proteomic analysis of in Sauton culture filtrate of Map submitted to different stress conditions
(hypoxia, acidic pH, nutrient starvation or non-toxic NO) as described for M. tuberculosis by
Voskuil et al. [28]. In total, seven proteins were found to be up-regulated under stress condi-
tions (highlighted in grey) (Roupie et al., manuscript in preparation). The 35 proteins were
produced as recombinant histidine-tagged proteins in E. coli and purified by affinity chroma-
tography on immobilized nickel-chelate (Ni-NTA) columns.
Virulence and genetic diversity of M. hominissuis
PLOS ONE | DOI:10.1371/journal.pone.0171895 February 9, 2017 5 / 19
Table 2. List of 35 recombinant M. avium subsp. paratuberculosis antigens.
Nr. Antigen Description E value Ident. Accession Myco
1 MAP0139c transcriptional regulator, PadR family protein [Mycobacterium avium 104] 8,00E-
144
99% ABK65696.1 MAA104
2 MAP0586c transglycosylase SLT domain protein [Mycobacterium avium 104] 0 99% ABK65241.1 MAA104
3 MAP0907 morphine 6-dehydrogenase [Mycobacterium avium 104] 0 98% ABK68334.1 MAA104
MAP0907 oxidoreductase [Mycobacterium avium subsp. hominissuis TH135] 1,00E-
52
41% BAN32966.1 MAH
TH135
4 MAP1438c alpha/beta hydrolase fold domain protein [Mycobacterium avium 104] 0 99% ABK65668.1 MAA104
MAP1438c alpha/beta hydrolase [Mycobacterium avium subsp. hominissuis TH135] 2,00E-
24
40% BAN33440.1 MAH
TH135
5 MAP1562c conserved hypothetical protein [Mycobacterium avium 104] 1,00E-
89
100% ABK66813.1 MAA104
6 MAP1693c-FL peptidyl-prolyl cis-trans isomerase, fkbp-type domain protein [Mycobacterium
avium 104]
1,00E-
125
98% ABK64725.1 MAA104
MAP1693c-FL peptidyl-prolyl cis-trans isomerase domain-containing protein
[Mycobacterium avium subsp. hominissuis TH135]
4,00E-
113
100% BAN31629.1 MAH
TH135
7 MAP2411 pyridoxamine 5-phosphate oxidase [Mycobacterium avium subsp.
hominissuis 10–4249]
9,00E-
101
100% ETB30907.1 MAH
8 MAP2677c glyoxalase family protein [Mycobacterium avium 104] 8,00E-
92
98% ABK69112.1 MAA104
9 MAP2746 hypothetical protein MAH_1788 [Mycobacterium avium subsp. hominissuis
TH135]
4,00E-
119
98% BAN30862.1 MAH
TH135
MAP2746 conserved hypothetical protein [Mycobacterium avium 104] 2,00E-
109
99% ABK64828.1 MAA104
10 MAP-CF036-Ag3 integral membrane protein YrbE1A [Mycobacterium avium subsp.
hominissuis TH135]
3,4 20% BAN33502.1 MAH
TH135
MAP-CF036-Ag3 conserved hypothetical protein [Mycobacterium avium 104] 3,4 20% ABK66937.1 MAA104
11 MAP3385 methyltransferase [Mycobacterium avium subsp. hominissuis TH135] 8,00E-
65
64% BAN32924.1 MAH
TH135
MAP3385 hypothetical protein MAH_3962 [Mycobacterium avium subsp. hominissuis
TH135]
2,00E-
64
44% BAN33036.1 MAH
TH135
MAP3385 methyltransferase, putative, family protein [Mycobacterium avium 104] 5,00E-
32
40% ABK67089.1 MAA104
12 MAP3486 lactate 2-monooxygenase [Mycobacterium avium 104] 0 99% ABK65670.1 MAA104
MAP3486 LldD2 protein [Mycobacterium avium subsp. hominissuis TH135] 4,00E-
35
32% BAN31520.1 MAH
TH135
13 MAP3547c hypothetical protein MAV3388_23345 [Mycobacterium avium subsp.
hominissuis 3388]
0 99% KDO92449.1 MAH
MAP3547c conserved hypothetical protein [Mycobacterium avium 104] 2,00E-
17
26% ABK65078.1 MAA104
14 MAP3680c Formate dehydrogenase [Mycobacterium avium subsp. hominissuis TH135] 0 99% BAN33415.1 MAH
TH135
MAP3680c formate dehydrogenase [Mycobacterium avium 104] 0 99% ABK68013.1 MAA104
15 MAP3731c O-antigen export system ATP-binding protein RfbB [Mycobacterium avium
104]
0,13 21% ABK65477.1 MAA104
MAP3731c O-antigen export system ATP-binding protein RfbB [Mycobacterium avium
subsp. hominissuis TH135]
0,16 21% BAN29326.1 MAH
TH135
16 MAP3804 glycosyl hydrolases family protein 16 [Mycobacterium avium 104] 0 100% ABK67366.1 MAA104
MAP3804 glycosyl hydrolases family protein 16 [Mycobacterium avium subsp.
hominissuis TH135]
7,00E-
174
100% BAN33331.1 MAH
TH135
17 MAP4096 nitroreductase family protein [Mycobacterium avium 104] 6,00E-
115
99% ABK64565.1 MAA104
MAP4096 nitroreductase [Mycobacterium avium subsp. hominissuis TH135] 2,00E-
04
23% BAN29848.1 MAH
TH135
(Continued )
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Table 2. (Continued)
Nr. Antigen Description E value Ident. Accession Myco
18 MAP4308c fructose-bisphosphate aldolase class-I [Mycobacterium avium 104] 0 99% ABK68800.1 MAA104
19 Ag5 hypothetical protein MAPs_16490 [Mycobacterium avium subsp.
paratuberculosis S397]
2,00E-
166
100% EGO37081.1 MAP
20 Ag6 MULTISPECIES: ATP-dependent helicase [Mycobacterium avium complex
(MAC)
0,047 39% WP_038536272.1 MAC
21 MAP1637c M. avium UbD family decarboxylase 0,00E
+00
99% WP_016706304.1 M. avium
22 MAP0388 hypothetical protein MAP_0388 [Mycobacterium avium subsp.
paratuberculosis K-10]
0 99% AAS02705.1 MAP
23 MAP3743-Ag9 hypothetical protein MAP_3743 [Mycobacterium avium subsp.
paratuberculosis K-10]
0 99% AAS06293.1 MAP
24 MAP3744m-
Ag10
thiazolinyl imide reductase [Mycobacterium avium subsp. paratuberculosis
10–4404]
0 99% ETB06990.1 MAP
24 MAP3744m-
Ag10
thiazolinyl imide reductase [Mycobacterium avium] 0 99% WP_016705779.1 M. avium
25 MAP0217 antigen 85-C [Mycobacterium avium 104] 7,00E-
180
99% ABK64781.1 MAA104
MAP0217 antigen 85-C protein [Mycobacterium avium subsp. hominissuis TH135] 3,00E-
179
99% BAN29303.1 MAH
TH135
26 MAP0353 glycerol kinase [Mycobacterium avium 104] 0 99% ABK67587.1 MAA104
27 MAP1166 RecName: Full = Triosephosphate isomerase; Short = TIM; Short = TPI;
AltName: Full = Triose-phosphate isomerase
0 99% A0QHY3.1 MAA104
28 MAP1362 arginine biosynthesis bifunctional protein ArgJ [Mycobacterium avium 104] 9,00E-
145
99% ABK65024.1 MAA104
29 MAP1803 dienelactone hydrolase [Mycobacterium avium subsp. hominissuis TH135] 4,00E-
166
99% BAN31765.1 MAH
TH135
MAP1803 dienelactone hydrolase family protein [Mycobacterium avium 104] 2,00E-
143
99% ABK69268.1 MAA104
30 MAP2800 enoyl-CoA hydratase [Mycobacterium avium 104] 0 99% ABK64508.1 MAA104
MAP2800 enoyl-CoA hydratase [Mycobacterium avium subsp. hominissuis TH135] 2,00E-
24
30% BAN30137.1 MAH
TH135
31 MAP2864c dihydrodipicolinate synthase [Mycobacterium avium 104] 0 99% ABK66322.1 MAA104
32 MAP3413 aldehyde dehydrogenase (NAD) family protein [Mycobacterium avium 104] 0 99% ABK69290.1 MAA104
MAP3413 P-cumic aldehyde dehydrogenase [Mycobacterium avium subsp. hominissuis
TH135]
3,00E-
41
27% BAN31590.1 MAH
TH135
33 MAP3634 ErfK/YbiS/YcfS/YnhG family protein [Mycobacterium avium 104]Lipoprotein
lprQ
0 100% ABK64614.1 MAA104
MAP3634 hypothetical protein MAH_1464 [Mycobacterium avium subsp. hominissuis
TH135]
6,00E-
48
41% BAN30538.1 MAH
TH135
34 MAP3668c phosphotriesterase-like protein [Mycobacterium avium subsp. hominissuis
TH135]
0 99% BAN33426.1 MAH
TH135
MAP3668c phosphotriesterase-like protein [Mycobacterium avium 104] 0 99% ABK64738.1 MAA104
35 MAP2541c Malate dehydrogenase 0 99% A0QCI6.1 MAA104
Ags 1–18: Map antigens identified by proteomic and immunoproteomic analysis of Map culture filtrate [26]; Ags 19–24: Map antigens identified by in silico
predictions [27]; Ags 25–35: Map antigens identified in Map cultures submitted to stress conditions: nutrient starvation, hypoxia or acidic pH (Roupie et al.,
manuscript in preparation). Proteins actually upregulated in stress conditions are highlighted in grey. Putative function and results of BlastP comparison (E
value and % protein identity) with Mah104 and Mah TH135 genome.
doi:10.1371/journal.pone.0171895.t002
Virulence and genetic diversity of M. hominissuis
PLOS ONE | DOI:10.1371/journal.pone.0171895 February 9, 2017 7 / 19
Antibody responses
Pooled sera of five mice infected by the porcine MST12 isolate were collected at week 20 post-
infection and analyzed for mycobacteria-specific IgG antibodies against whole Map culture fil-
trate by ELISA and against the 35 recombinant Map proteins (100 ng/well in borate buffer)
using a dot-blot coupled to Western blot using pooled sera/group diluted 1:50, peroxidase-
labelled rat anti-mouse IgG (LO-MK-1, purchased at Experimental Immunology Unit, Uni-
versite´ Catholique de Louvain, Brussels, Belgium) diluted 1:500 and α-chloronaphtol (Sigma-
Aldrich, St. Louis, MO, USA) in H2O2 for revelation. Reaction was stopped by washing in tap
water. As the dot-blot assay required serum volumes in the order of 0.5 mL, sera were pooled.
Non-infected mice were used as negative control.
Statistical analysis
GraphPad Prism software (San Diego, CA, USA) was used to perform statistical analysis. One-
way ANOVA (with Tukey’s post-t-tests) and Student t tests were performed to demonstrate
statistical differences. For all tests p-values < 0.05 were considered significant.
Results
Bacterial replication of 8 Mah isolates in intranasally infected BALB/c
mice
BALB/c mice were infected by the intranasal route with 107 CFU of the eight Mah isolates
listed in Table 1. Virulence of the strains was examined, by enumeration of the bacteria in
lungs, spleen and liver at week 1, 5, 12 and 20, as previously reported for testing Map virulence
[18]. Pronounced differences were observed in bacterial replication of the eight isolates and
their MST type seemed to correlate with this variation for four of them (Fig 1). Thus, the
human and porcine isolates with shared MST22 (in red) showed a more than 1,000 fold
increase in bacterial numbers in lungs (6.5 log10 at week 1 to 10 log10 at week 20) and a dra-
matic dissemination to spleen (2 log10 at week 1 to 8 log10 at week 20) and liver (3.5 log10 at
week 1 to 8 log10 at week 20), whereas the human and porcine isolates with shared MST91 (in
green) showed no replication in lungs (stable CFU counts at 6.5 log10 throughout the entire
period) or liver (stable CFU counts at 3 log10) and minor dissemination to spleen (1.0 log10 to
3 log10). For the two MST12 isolates, the link with bacterial replication was less clear as the
porcine MST12 isolate replicated to the same extent as the two MST22 isolates, whereas the
human MST12 isolate showed intermediate virulence. Porcine MST103 finally also showed an
intermediate replication and human MST15 isolate finally replicated to a minor extent in the
lungs, but did not disseminate to liver or spleen.
Another infection run was realized with seven of these eight Mah strains. The results of this
run (lacking the Hu15 isolate, and with time-point measures at 5, 9 and 20 weeks post-infec-
tion) are shown in S1 Fig. A similar variation in bacterial replication, associated with a thou-
sand fold increase in bacterial numbers in lungs of mice infected with the two MST22 isolates
and the porcine MST12 isolate and a stable number of bacteria in the lungs of mice infected
with the two MST91 isolates was observed.
Cytokine production
At five weeks post-infection, strong IFN-γ production was detected in response to M. avium
culture filtrate (and PPD, data not shown) in mice infected with MST12 and MST22 isolates
(ranging between 20,000 and 40,000 pg/mL), whereas IFN-γ levels were about tenfold lower in
mice infected with MST91 isolates (Fig 2). At week 20 p.i., IFN-γ responses induced by M.
Virulence and genetic diversity of M. hominissuis
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Fig 1. Bacterial replication in lungs (A), spleen (B) and liver (C) of BALB/c mice infected with one of
the eight Mah isolates, as measured at 1, 5, 12 and 20 weeks post-infection. Data represent mean CFU
(log10)/organ ± SEM of five animals tested per group. Isolate IDs represent the host (Hu: human; Po: swine)
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avium CF were completely abrogated in mice infected with the human and porcine MST22
and the porcine MST12 isolates, whereas IFN-γ responses in mice infected with both Mah
MST91 isolates were sustained at levels even slightly, although not significantly higher than at
the early time point (Figs 2 and 3A).
In order to find out, whether the suppressed IFN-γ response at 20 weeks post-infection in
spleen of MST22 infected mice was the result of a shift from Th1 to Th2, Th17 or Treg helper
T cell phenotype, we measured the production of IL-4, IL-10, IL-17 and IL-1β by ELISA in
week 5 and week 20 spleen cell culture supernatants of mice infected with the two MST22 and
the two MST91 isolates. At week 5, only weak IL-10 levels were detected in culture superna-
tants of the four groups (data not shown), but at week 20 a significantly higher IL-10 produc-
tion was measured in supernatants of MST22 than of MST91 infected mice (p<0.005) (Fig
3B), suggesting that the abrogated IFN-γ response in the MST22 infected mice may have been
the result of an activation of IL-10 producing regulatory macrophages and/or T cells. IL-17
could be detected only in week 20 culture supernatants (Fig 3C). In MST22 infected mice, lev-
els of IL-17 were comparable in supernatants from non-stimulated or CF-A stimulated cells,
whereas in MST91 infected mice, stimulation with CF-A induced increased IL-17 production
as compared to non-stimulated cells. IL-4 levels were below detection level at the two time
followed by the respective multispacer sequence type (MST). Statistical significance is depicted for each
strain as compared to both Po91 and Hu91 (*: p<0.05).
doi:10.1371/journal.pone.0171895.g001
Fig 2. Spleen cell IFN-γ production in response to M. avium culture filtrate (5 μg/mL) in BALB/c mice infected for 5 weeks (filled bars) or
20 weeks (striped bars) with the different Mah isolates. Results represent mean IFN-γ levels (pg/mL) ± SEM of 3–5 mice tested individually.
Statistical significance is depicted for each human or porcine strain as compared to respectively Hu91 or Po91 (*: p<0.05). N.A.: not available.
doi:10.1371/journal.pone.0171895.g002
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Fig 3. IFN-γ (A), IL-10 (B) and IL-17 (C) production in 72h spleen cell culture supernatant of mice infected
for 20 weeks with human and porcine MST22 (red) and human or porcine MST91 (green) Mah isolates.
Cells were unstimulated (filled bars) or stimulated with culture filtrate (striped bars). Results represent mean
Virulence and genetic diversity of M. hominissuis
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points for all four Mah groups, and very weak IL-1β levels were detected that were not different
between the two time points and the four Mah groups (data not shown).
IFN-γ production and IgG antibodies in response to 35 recombinant,
purified Map antigens in Mah infected BALB/c mice
A series of 35 M. avium subsp. paratuberculosis protein sequences were compared for identity
with proteins in Mah 104 and Mah TH135, using BlastP (Table 2). Except for the six in silico
predicted antigens (antigens 19–24 in Table 2), predicted identity between the Map and Mah
proteins was in the order of 99% for twenty-six of the twenty-nine other proteins (Table 2).
Three MAP proteins, i.e. Ag 3, MAP3385 and MAP3731, showed a lower percentage of iden-
tity with Mah of 20%, 64% and 21% respectively. In view of these strong identities and as
cloned and purified Mah products were not available, we tested the purified Map proteins in
an IFN-γ release assay (Fig 4). Nine of the thirty-five antigens induced strong IFN-γ responses
(> 4,000 pg/mL) at week 5 p.i. in spleen cell cultures from mice infected with virulent porcine
MST12: MAP3680c a formate dehydrogenase, MAP0217 (Ag85C) a member of the highly
conserved immunodominant Ag85 family, which functions as mycolyl-transferase involved in
the coupling of trehalose to the arabinogalactan of the mycobacterial cell wall [29], MAP1803
belonging to the dienelactone hydrolase family protein, MAP2800 predicted to be an enoyl-
CoA hydratase and MAP2541 finally a malate dehydrogenase. Somewhat surprisingly, the
hypothetical proteins Ag5, MAP0388, MAP3743 and the predicted thiazolinyl imide reductase
MAP3744, all four previously selected in silico (and for which a new blast analysis confirmed
the absence of homology with other M. avium subspecies) also stimulated a strong IFN-γ pro-
duction in spleen cells of mice infected with the MST12 Mah isolate.
cytokine levels (pg/mL) ± SEM of 5 mice tested individually in each group. Statistical significance is depicted for
MST22 strains as compared to MST91 strains (*: p<0.05; **: p<0.005; n.s.: non-significant).
doi:10.1371/journal.pone.0171895.g003
Fig 4. IFN-γ response of BALB/c mice infected intranasally with porcine MST12 isolate (Po12). Mice (n = 5) were sacrificed 5 weeks post-infection
and pooled spleen cells were stimulated for 72h with each of the 35 Map antigens (5 μg/mL). IFN-γ levels are expressed in pg/mL.
doi:10.1371/journal.pone.0171895.g004
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Serial dilutions of pooled sera of BALB/c mice infected for 20 weeks with porcine Po12 and
human Hu12 or sera from non-infected mice were tested against M. avium CF by ELISA (Fig
5A). Strong CF-A specific antibodies were detected in sera from Mah Po12 and Hu12 infected
mice. Pooled sera from Mah Po12 infected mice were also tested against the 35 Map antigens
in a dot-blot assay (Fig 5B). Two proteins were strongly recognized (Nr.10/CF-036 and Nr.33/
MAP3634, homologous to lprQ lipoprotein) and five proteins (Nr.3/MAP0907, a predicted
morphine 6-dehydrogenase, Nr.8/MAP2677c of the glyoxalase family protein, Nr.19/Ag5,
Nr.29/MAP1803 and Nr.35/MAP2541c) were recognized but more weakly in the dot-blot.
These results are consistent with other dot-blot experiments in which MAP3634 was also very
strongly recognized by sera from M. avium subsp. avium infected mice (data not shown), sug-
gesting this antigen had a potential for serodiagnosis.
Comparison of sequences of MST22 and MST91 isolates with
sequences of two Mah reference strains
As differences in MST type seemed to be reflected (at least to some extent) by differences in
virulence in BALB/c mice, whole genome sequencing of the two MST22 and the two MST91
isolates was performed, sequences have been deposited at the European Nucleotide Archive
and genome statistics of the four isolates was reported [19]. MST22 rather than MST12 isolates
were chosen for sequencing because of the limited clinical information for the human MST12
isolate.
Next, the genome sequences of MST22 and MST91 isolates were compared with two M.
avium subsp. hominissuis reference strains, i.e. Mah 104 and Mah TH135, isolated from an
AIDS patient with disseminated disease and a HIV-negative patient with pulmonary disease
respectively. In a very interesting study, the genome of these two reference strains was com-
pared by Uchiya et al. and described to encode for a series of specific virulence factors [21].
Fig 5. A: IgG antibodies against M. avium culture filtrate in serial dilutions of pooled sera of BALB/c mice infected for 20
weeks with porcine (blue circles) or human (blue squares) Mah MST12 isolate (pooled sera from naïve mice represented by
black dots). B: Plate organization and Western blot image of immunoblot of week 20 pooled Mah Po12 serum tested against
the 35 Map antigens. Numbers of the two antigens giving the strongest signals are indicated in blue, numbers of the five
antigens giving weaker signals are indicated in red.
doi:10.1371/journal.pone.0171895.g005
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Here, we analyzed whether the sequences of these virulence factors were also present in the
genome of the MST22 and MST91 isolates (Table 3). One gene sequence from the Mah
TH135 reference strain, namely MAH_1657, and ten other sequences from the Mah 104 refer-
ence strain were found to be present at 100% identity in both MST22 isolates (Hu22 and
Po22). For the MST91 isolates, only two gene sequences (MAV_0117 and MAV_0953) were
found to be identical with the sequence of the genes reported from the reference strain Mah
104. Interestingly, the nine gene sequences present in the two virulent isolates of genotype 22
and coding for specific virulence factors of the mammalian cell entry (Mce family) are indeed
absent in the two avirulent isolates of genotype 91. Among these nine genes, five were localized
by Uchiya et al. in a SR21 strain-specific region identified in the Mah 104 reference strain [21].
Besides the Mce genes, two genes identical to PPE proteins were found in MST22 isolates:
MAH_1657 (TH135) sharing 100% identity and MAV _1347 (104) 99% identical with M.
avium subsp. avium. Genomes of the two MST91 isolates had an identical copy MAV_0117,
encoding a PE protein, 99% identical with M. avium subsp. avium. Finally, BlastN analysis did
not reveal any sequence homology in our four Belgian isolates with the plasmid pMAH135
(data not shown), which was reported to be associated with progression to pulmonary disease
in Japan [30].
Discussion
A worldwide increase in the prevalence of human nontuberculous mycobacterial (NTM)
infections has been observed since 2000 [31]. NTM infections are thought to be triggered
essentially by exposure to environmental NTM that reside in soil and water. In recent years it
has become clear that members of the Mycobacterium avium complex such as the subspecies
M. avium subsp. hominissuis (Mah) cause a problem in immunocompetent adults (mostly
respiratory tract infections) and children (lymphadenitis) as well as in immunocompromised
AIDS patients [32,33]. Interestingly, advancement in sequence-based identification and geno-
typing has demonstrated a remarkable genetic diversity of the Mah subspecies [2].
On the basis of multisequence typing, we selected four swine and four human Mah isolates
for a detailed analysis of in vivo virulence and confirmed a strong variation between the differ-
ent isolates. Monitoring bacterial replication in the lungs over a period of 20 weeks, a human
Table 3. Genes present at 100% identity in the sequenced Mah strains.
Genes identified by [21] in reference strain Mah TH135
Gene sequence name Predicted protein Presence in Hu22 Presence in Po22 Presence in Hu91 Presence in Po91
MAH_1657 PPE X X
Genes identified by [21] in reference strain Mah 104
Gene sequence name Predicted protein Presence in Hu22 Presence in Po22 Presence in Hu91 Presence in Po91
MAV_RS00575/MAV_0117 PE X X
MAV_RS04540/MAV_0948 Mce X X
MAV_RS04550/MAV_0950 Mce X X
MAV_RS04555/MAV_0951 Mce X X
MAV_RS04565/MAV_0953 Mce X X
MAV_RS06460/MAV_1347 PPE X X
MAV_RS24220/MAV_5047 SR-21 Mce X X
MAV_RS24225/MAV_5048 SR-21 Mce X X
MAV_RS24230/MAV_5049 SR-21 Mce X X
MAV_RS24240/MAV_5051 SR-21 Mce X X
MAV_RS24245/MAV_5052 SR-21 Mce X X
doi:10.1371/journal.pone.0171895.t003
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and porcine isolate with MST22 type were found to be highly virulent, whereas a human and
porcine isolate with MST91 type were found to be fully avirulent. Mycobacteria-specific IFN-γ
responses were highest in mice infected with the virulent isolates early during infection, but at
the late stage, these responses were markedly suppressed and in parallel IL-10 responses were
increased. These findings are reminiscent of the report of Roque et al. who compared the sus-
ceptibility of BALB/c and C57BL/6 mice to intravenous infection with M. avium subsp. avium
strain 2447 and showed that the higher susceptibility of BALB/c than of C57BL/6 mice was
related to higher IL-10 responses in the former strain [34]. In contrast, mice infected with Mah
MST91 isolates, showed more modest but sustained IFN-γ levels throughout the entire study
period, and at the late time point significant mycobacteria-specific IL-17 production could be
measured, reflecting the presence of a possibly protective Th17 memory T cell population in
mice infected with these Mah isolates of which the multiplication was controlled. Also in NTM
patients with nodular bronchiectasis, it was suggested that susceptibility to pulmonary disease
may reflect low IL-17 and high IL-10 responses, rather than a Th1 deficiency [35].
Immunodiagnosis of M. avium infection is hampered by the lack of specific antigens. Avian
and bovine tuberculins (which are purified protein derivatives of autoclaved bacteria) are the
reagents commercially available to assess exposure to Map in cell-mediated immune assays
such as intradermal skin tests and IFN-γ release assays, but these assays are hampered by the
presence in PPDs of many cross-reactive antigens. The use of M. avium specific antigens may
help to overcome this specificity issue if a sufficient sensitivity could be obtained. By screening
a series of 35 antigens, many predicted to be specific for M. avium, we identified here some
protein candidates that hold promise for the detection of early infection using IFN-γ release
assays (CF-036 and MAP2541c) and for the serodiagnosis of multibacillary disease (MAP3634).
The MAP3634 antigen (new name MAP_RS18645) has a predicted function of a lipoprotein-
anchoring transpeptidase, also known as lipoprotein LprQ. Interestingly, other lipoproteins
such as the phosphate-binding protein PstS-1 of M. tuberculosis [36] and PstS-2 and PstS-3 of
M. bovis BCG [37,38] are known to be powerful B cell antigens. A detailed analysis of the immu-
nodiagnostic potential of these 35 proteins in cattle is in progress (Roupie et al., manuscript in
preparation).
As stated by Winthrop et al., “studies of NTM pathogenesis and host immunity to NTM
have been hampered by the lack of a robust animal model that can mimic human non-dissemi-
nated MAC pulmonary disease” [39]. Studies in non-human primates such as rhesus macaques
could be a solution, but our results show that an intranasal infection of BALB/c mice with a
properly selected avirulent strain such as the Mah MST91 could be a valuable alternative.
Uchiya et al. reported on genetic diversity in Mah strains that cause pulmonary and dissem-
inated disease, and performed a comparative genome analysis of MahTH135, isolated from a
HIV-negative patient with pulmonary disease [21] and Mah104, isolated from an adult AIDS
patient in Southern California in 1983. The sequenced genome of M. avium strain 104 has
been associated with disease in multiple patients in the western United States. Although M.
avium is known for its genetic plasticity, this observation indicates that certain strains of the
pathogen such as the Mah 104 isolate can be genotypically stable over extended periods of
time [20]. In our study, the virulent human Mah MST22 strain was isolated from a 40 year old
HIV-negative man with disseminated disease and the avirulent human Mah MST91 strain
from a 40 year old AIDS patient with disseminated disease. Whole genome sequencing of
these two human isolates was performed (in parallel with the MST22 and MST91 pig isolates)
[19] and sequences were compared to the Mah TH135 and Mah 104 sequence, with respect to
twenty-five candidate strain 104 specific genes and to twenty-two candidate strain TH135 spe-
cific genes, reported by Uchiya [21]. Porcine and human sequences aligned according to their
MST type, and the two MST22 isolates had ten identical Mah strain 104 specific genes and one
Virulence and genetic diversity of M. hominissuis
PLOS ONE | DOI:10.1371/journal.pone.0171895 February 9, 2017 15 / 19
Mah TH135 gene, whereas the two MST91 isolates had only 2 genes identical with Mah strain
104 (Table 3). Among the nine putative Mce proteins identical in the MST22 isolates, five are
localized in the strain-specific SR-21 region of the reference 104 strain, region with a sequence
similarity of 70–75% with M. abscessus [21]. Although the precise mechanisms involving Mce
proteins in virulence remain unclear, these proteins are thought to help mycobacteria to enter
into macrophages, but they have also been implicated in uptake of cholesterol essential for
long term survival in host cells.
Thus, genomic comparison indicated that the human and porcine MST22 isolates, were
much more similar to the reference Mah 104 type than to the Mah TH135 type with respect to
predicted virulence factors. Mah isolates exhibit geographic differences in genetic diversity,
with isolates from Japan (such as Mah TH135) sharing a high degree of relatedness with
Korean isolates, but not with isolates from Europe or the United States [2]. The strong genetic
similarity of the human MST22 strain isolated in 2012 in Belgium (from an HIV-negative
patient) with the Mah 104 strain (isolated in 1983 in the USA from an AIDS patient) seems to
indicate that genetic differences are determined by the geographic origin rather than by the
type of clinical symptoms. On the other hand, Moriyama et al. reported recently on an associa-
tion between the presence of a pMAH135 plasmid in Mah isolates and the progression of
pulmonary disease [30]. Interestingly, although a plasmid seems indeed to be involved for Jap-
anese isolates, in our study, careful genome comparison failed to find any homology with the
pMAH135 sequence in the four Belgian isolates.
In conclusion, our results show that intranasal infection of BALB/c mice can be used as a
reliable experimental model to analyse variations in virulence of different Mah isolates. Very
recently, Uchiya et al. performed a comparative genome analysis of 79 M. avium strains and
on the basis of single nucleotide polymorphisms a phylogenetic tree was drawn [40]. The four
Belgian Mah isolates were included in the study and they localized on the phylogenetic tree
two by two according to their MST genotype, more specifically in the IIa subcluster [40].
Therefore, the striking link of virulence and identity at the genome level of porcine and
human isolates with the same multisequence type, for which no correlation of place of resi-
dence (humans) or farm of origin (pigs) was observed, points to the presence in the environ-
ment of certain genotypes of Mah which may be more infectious for both humans and pigs
than other genotypes.
Supporting information
S1 Fig. Bacterial replication in lungs (A), spleen (B) and liver (C) of BALB/c mice infected
with one of the seven Mah isolates, as measured at 2, 5, 9 and 20 weeks post-infection. Data
represent mean CFU (log10)/organ ± SEM of five animals tested per group. Isolate IDs repre-
sent the host (Hu: human; Po: swine) followed by the respective multispacer sequence type
(MST). Statistical significance is depicted for each strain as compared to both Po91 and Hu91
(: p<0.05).
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